Actinium Pharmaceuticals Inc (ATNM) stock is down -15.83% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives ATNM stock a score of 68 out of a possible 100.
That rank is primarily influenced by a long-term technical score of 72. ATNM's rank also includes a fundamental score of 70. In addition to the average rating from Wall Street analysts, ATNM stock has a mean target price of $35.00. This means analysts expect the stock to rise 448.59% over the next 12 months. The short-term technical score for ATNM is 62.
ATNM has an Overall Score of 68. Find out what this means to you and get the rest of the rankings on ATNM!
Actinium Pharmaceuticals Inc (ATNM) stock is lower by -2.74% while the S&P 500 is higher by 0.68% as of 11:20 AM on Wednesday, Apr 13. ATNM is down -$0.18 from the previous closing price of $6.56 on volume of 1,245,887 shares. Over the past year the S&P 500 is higher by 6.90% while ATNM is down -15.83%. ATNM lost -$1.20 per share in the over the last 12 months.
Click Here to get the full Stock Report for Actinium Pharmaceuticals Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter